A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs With Spontaneous Activated B-Cell Like Diffuse Large B-Cell Lymphoma

PLoS ONE - United States
doi 10.1371/journal.pone.0095404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Bone Marrow Molecular Markers Associated With Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

The Proportion of Activated B-Cell Like Subtype Among De Novo Diffuse Large B-Cell Lymphoma Increases With Age

Haematologica
Hematology
2011English

Diffuse Large B-Cell Lymphoma

2020English

Diffuse Large B-Cell Lymphoma Presenting With Cholecystitis-Like Symptoms

Korean Journal of Clinical Oncology
2018English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Establishing a Model System for Evaluating CAR T Cell Therapy Using Dogs With Spontaneous Diffuse Large B Cell Lymphoma

OncoImmunology
OncologyAllergyImmunology
2019English

Diffuse Large B-Cell Lymphoma Presenting in the Leukemic Phase

Autopsy and Case Reports
2016English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy